At first, tests of normality revealed that the data were non-normally distributed (p < 0.0001, Kolmogorov–Smirnov Test); hence, the median CIAPIN1 expression value of the CCA group was used as a cut-off. The gene discussed is CIAPIN1; the disease is cholangiocarcinoma.